Page 2 - Dr. Reddy's

MNCs partner Indian firms to boost market reach in pharmaceutical sector

MNC's like AstraZeneca's have also collaborated with Mankind Pharma to distribute asthma medication in India further highlights this trend's reach across therapeutic areas

Dr Reddy's Laboratories acquires women's health brands from MenoLabs

DRL said that it has acquired the entire MenoLabs supplements portfolio, which includes seven branded products designed to provide health support and address symptoms of perimenopause and menopause

Dr Reddy's launches wearable device for drug-free management of migraine

In January this year, Dr Reddy's entered an exclusive agreement with Theranica for the marketing and distribution of Nerivio in India

Dr Reddy's Q2 results: Net profit after tax rises 33% to Rs 1,482 crore

Consolidated quarterly revenue rose 9% to 69.03 billion rupees led by a 9% growth in the key global generics segment

Cipla on the block: Who's a better fit and what it means for shareholders?

As per IIFL Securities, Cipla with a dominating market share of 7% and 23% in acute therapies like respiratory and anti-infectives, respectively, would strengthen Torrent's position in these

Dr Reddy's selects Amazon Web Services as preferred cloud provider

Amazon Web Services (AWS) on Monday announced that Dr. Reddy's Laboratories has selected it as preferred cloud provider to help provide access to affordable and innovative medicines. As part of the collaboration, the company has migrated its SAP platform entirely onto AWS. "By centralising the platform on the world's leading cloud, Dr. Reddy's will accelerate the development of new healthcare applications, grow its digital platform to help the organisation serve more than 1.5 billion patients by 2030 around the world, and enable healthcare providers to better track the progress of patients," according to a statement. Since 2019, Dr. Reddy's has been progressively creating and migrating digital applications to AWS to automate the company's IT infrastructure. "Leveraging AWS, Dr. Reddy's has made healthcare more accessible by launching new applications faster, to provide better service to its customers," the statement said. With AWS, Dr. Reddy's aims to reduce application developmen

Stocks to Watch today, July 10: Cyient DLM, Titan, SBI, Zee, IOC, HDFC Bank

Stocks to watch on July 10, 2023: BHEL, Delta Corp, Granules and India Cements are the four stocks in F&O ban period on Monday.

DRL enters trade generics, aims to be among top five players in market

Exploring strategic collaborations in the country, says pharma firm

Bias for Nifty likely to remain bearish below 17,210: HDFC Securities

Among individual stocks, the technical & derivative analyst from HDFC Securities recommends to Buy Mahanagar Gas and Dr.Reddy's Labs.

Eris Lifesciences buys dermatology brands from Dr Reddy's for Rs 275 crore

In January Eris had bought some derma brands from Glenmark Pharma as well

Here's why Vinay Rajani is bullish on Dr Reddy's, Oracle Financial Services

As per the technical analyst, the Budget session high of 17,973 and low of 17,353 have become crucial levels to watch out for any directional move in the Nifty index

Stocks to Watch: Adani Group, Tata Motors, Dr.Reddy's, DLF, Airtel, IGL

Stocks to Watch: Adani Enterprises FPO and Earthstahl & Alloys IPO opens for subscription on Friday. Shares of Adani Group companies also likely to be in focus amid the Hindenburg controversy.

Dr Reddy's acquires trademark rights for Pfizer breast cancer drug

Dr. Reddy's plans to roll out a unique Patient Assistance Programme to support long-term therapy of the patients on Primcyv

Inflows in Tata Motors stock may surge as it replace Dr Reddy's in Sensex

Change effective from Dec 19, but adjustment will take place on Dec 16. After DRL's deletion, Sun Pharma will be the only healthcare stock in the index

Stocks to watch: SBI, DRL, Britannia, Coal India, Divi's Lab, Paytm, ABFRL

Stocks to watch today: Coal India, Divi's Lab will report the July-September quarter (Q2FY23) results on Monday, November 7; SBI's net profit climbed 73.9 per cent YoY to Rs 13,265 crore in Q2FY23

Wockhardt likely to sell India business to cut debt, focus on UK: Analysts

Company left with low-margin brands in India after selling profitable ones

Stocks to Watch: Torrent Pharma, ONGC, Dr Reddy's, BHEL, BPCL, Birla Corp

Stocks to Watch: Dr Reddy's has received US FDA nod for marketing Timolol Maleate, which is used to treat Glaucoma

Stocks to Watch: NDTV, Dr.Reddy's, IndiGo, SBI, Zee, Consumer Firms

Stocks to Watch Today: NDTV open offer to start from October 17. IndiGo's co-promoter Rakesh Gangwal likely to sell up to 2.8 per cent stake in open market.

Stocks to watch: Titan, Dr Reddy's, Nelco, IOC, GIC Housing, Torrent Pharma

Stocks to watch today: Titan plans to add 20 to 30 Tanishq stores over two to three years in the Middle East and North America; Nelco inked pact with Intelsat to provide inflight connectivity services

Stocks to Watch: YES Bank, Cipla, Bank of Baroda, Zomato, HDFC, ITC, NTPC

Stocks to Watch today: ITC, UPL, Zomato, Arvind, Bajaj Consumer Care, among others will release their Q1 earnings today.